Literature DB >> 24743216

Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.

Sanjay Kakar1,2, James P Grenert1, Valerie Paradis3, Nicolas Pote3, Shriram Jakate4, Linda D Ferrell1.   

Abstract

Well-differentiated hepatocellular carcinoma in non-cirrhotic liver can show morphological features similar to hepatocellular adenoma. In rare instances, hepatocellular carcinoma can arise in the setting of hepatocellular adenoma. This study compares the immunohistochemical and cytogenetic features of the hepatocellular adenoma-like and hepatocellular carcinoma portions of these tumors. Immunohistochemistry for β-catenin, glutamine synthetase, serum amyloid A protein, glypican-3, and heat-shock protein 70 was done in 11 cases of hepatocellular carcinoma arising in hepatocellular adenoma in non-cirrhotic liver. Tumors with nuclear β-catenin and/or diffuse glutamine synthetase were considered β-catenin activated. Fluorescence in situ hybridization (FISH) was done in nine cases for gains of chromosomes 1, 8 and MYC. There were seven men (33-75 years) and four women (29-65 years). Focal atypical morphological features were seen in hepatocellular adenoma-like areas in 7 (64%) cases. Hepatocellular adenoma-like areas showed features of inflammatory hepatocellular adenoma in 7 (64%) cases; 4 of these were also serum amyloid A-positive in the hepatocellular carcinoma portion. β-Catenin activation, heat-shock protein 70 positivity, and chromosomal gains on FISH were seen in the hepatocellular adenoma portion in 55%, 40%, and 56% of cases, and 73%, 60%, and 78% of cases in the hepatocellular carcinoma portion, respectively. In conclusion, the hepatocellular adenoma-like portion of most cases of hepatocellular carcinoma arising in hepatocellular adenoma shows features typically seen in hepatocellular carcinoma such as focal morphological abnormalities, β-catenin activation, heat-shock protein 70 expression, and chromosomal gains. Hepatocellular adenoma-like areas in these tumors, especially in men and older women, may represent an extremely well-differentiated variant of hepatocellular carcinoma, whereas the morphologically recognizable hepatocellular carcinoma portion represents a relatively higher grade component of the tumor.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24743216      PMCID: PMC4803443          DOI: 10.1038/modpathol.2014.50

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  43 in total

1.  Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization.

Authors:  L Wilkens; M Bredt; P Flemming; T Becker; J Klempnauer; H H Kreipe
Journal:  J Pathol       Date:  2001-04       Impact factor: 7.996

2.  Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.

Authors:  T L Mao; J S Chu; Y M Jeng; P L Lai; H C Hsu
Journal:  J Pathol       Date:  2001-01       Impact factor: 7.996

3.  Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives.

Authors:  H Tesluk; J Lawrie
Journal:  Arch Pathol Lab Med       Date:  1981-06       Impact factor: 5.534

4.  Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives.

Authors:  M Davis; B Portmann; M Searle; R Wright; R Williams
Journal:  Br Med J       Date:  1975-11-29

5.  Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma.

Authors:  L Wilkens; M Bredt; P Flemming; Y Schwarze; T Becker; M Mengel; R von Wasielewski; J Klempnauer; H Kreipe
Journal:  J Mol Diagn       Date:  2001-05       Impact factor: 5.568

Review 6.  Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1.

Authors:  B R Balsara; J Pei; A De Rienzo; D Simon; A Tosolini; Y Y Lu; F M Shen; X Fan; W Y Lin; K H Buetow; W T London; J R Testa
Journal:  Genes Chromosomes Cancer       Date:  2001-03       Impact factor: 5.006

7.  Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.

Authors:  Ken Taniguchi; Lewis R Roberts; Ileana N Aderca; Xiangyang Dong; Chiping Qian; Linda M Murphy; David M Nagorney; Lawrence J Burgart; Patrick C Roche; David I Smith; Julie A Ross; Wanguo Liu
Journal:  Oncogene       Date:  2002-07-18       Impact factor: 9.867

8.  Prognostic significance of beta-catenin nuclear expression in hepatocellular carcinoma.

Authors:  Tsutomu Fujito; Yo Sasaki; Kyoko Iwao; Yasuo Miyoshi; Terumasa Yamada; Hiroaki Ohigashi; Osamu Ishikawa; Shingi Imaoka
Journal:  Hepatogastroenterology       Date:  2004 Jul-Aug

9.  Liver cell adenoma with concomitant hepatocellular carcinoma: report of two cases.

Authors:  Wen-Yu Chuang; Tse-Ching Chen; Hui-Ling Hsu; Wei-Chen Lee; Long-Bin Jeng; Shiu-Feng Huang
Journal:  J Formos Med Assoc       Date:  2002-11       Impact factor: 3.282

10.  Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.

Authors:  Makoto Chuma; Michiie Sakamoto; Ken Yamazaki; Tsutomu Ohta; Misao Ohki; Masahiro Asaka; Setsuo Hirohashi
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

View more
  14 in total

Review 1.  Malignant transformation of hepatocellular adenoma.

Authors:  Christine Sempoux; Charles Balabaud; Paulette Bioulac-Sage
Journal:  Hepat Oncol       Date:  2014-12-11

2.  Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.

Authors:  Juan Putra; Linda D Ferrell; Annette S H Gouw; Valerie Paradis; Arvind Rishi; Christine Sempoux; Charles Balabaud; Swan N Thung; Paulette Bioulac-Sage
Journal:  Mod Pathol       Date:  2019-09-30       Impact factor: 7.842

3.  Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma.

Authors:  Thuy B Nguyen; Massimo Roncalli; Luca Di Tommaso; Sanjay Kakar
Journal:  Mod Pathol       Date:  2016-01-15       Impact factor: 7.842

4.  Spontaneous hepatic haemorrhage secondary to ruptured hepatocellular adenoma in a young male patient.

Authors:  Peter Daechul Yoon; Andy Ze Lin Chen; David Tovmassian; Henry Pleass
Journal:  BMJ Case Rep       Date:  2020-08-25

5.  Overexpression of C-reactive Protein as a Poor Prognostic Marker of Resectable Hepatocellular Carcinomas.

Authors:  Jin Ho Shin; Chong Jai Kim; Eun Jeong Jeon; Chang Ohk Sung; Hwa Jeong Shin; Jene Choi; Eunsil Yu
Journal:  J Pathol Transl Med       Date:  2015-03-12

Review 6.  Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.

Authors:  Elan Hahn; Juan Putra
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

7.  miR-455 Inhibits the Viability and Invasion by Targeting RAB18 in Hepatocellular Carcinoma.

Authors:  Chenghong Wang; Guicai Zhu; Miaolin Yu; Xiufang Mi; Honghua Qu
Journal:  J Oncol       Date:  2021-05-27       Impact factor: 4.375

8.  Morphologic and Molecular Findings in Myxoid Hepatic Adenomas.

Authors:  Daniel J Rowan; Saba Yasir; Zongming E Chen; Taofic Mounajjed; Sibel Erdogan Damgard; Lisa Cummins; Lizhi Zhang; Emma Whitcomb; Vince Falck; Sanford M Simon; Aatur D Singhi; Michael S Torbenson
Journal:  Am J Surg Pathol       Date:  2021-08-01       Impact factor: 6.298

9.  Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.

Authors:  Gillian Hale; Xinxin Liu; Junjie Hu; Zhong Xu; Li Che; David Solomon; Christos Tsokos; Nafis Shafizadeh; Xin Chen; Ryan Gill; Sanjay Kakar
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

10.  MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis.

Authors:  Yue Li; You Li; Yao Chen; Qian Xie; Ningning Dong; Yanjun Gao; Huan Deng; Chunhua Lu; Suihai Wang
Journal:  Cancer Cell Int       Date:  2017-11-07       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.